Medinol articles

Background:

This paper describes a challenging case of implantation of the EluNIR™ Ridaforolimus eluting elastomeric stent (Medinol Ltd.). This complex case involved a patient with a flow-limiting lesion in a native coronary artery post bypass surgery.

The new EluNIR stent system includes a stent with a low metal footprint that comprises struts of variable width: ultra-narrow struts having a width of 40µm and narrow supportive struts h

Background

This paper outlines the first in-patient implantation of the EluNIR™ ridaforolimus eluting elastomeric stent (Medinol Ltd.). This complex case involved a patient with a flow-limiting lesion in a native coronary artery post bypass surgery.

The new EluNIR stent system includes a stent with a low metal footprint which comprises struts of variable width: ultra-narrow struts having a width of 40µm and narrow supportive struts hav